Vaborbactam is crucial in *pediatric* medicine due to the rising threat of antibiotic resistance. Children are particularly vulnerable to infections caused by multidrug-resistant organisms. The combination of meropenem and vaborbactam allows for the treatment of serious infections that might otherwise be difficult or impossible to treat with standard antibiotics.
